Average Co-Inventor Count = 7.41
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (36 from 289 patents)
2. Elmore Patent Law Group, P.c. (1 from 1 patent)
37 patents:
1. 12459923 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
2. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
3. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
4. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
5. 11958879 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
6. 11834436 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
7. 11718641 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
8. 11578097 - Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
9. 11560368 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
10. 11345699 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
11. 11040998 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
12. 11034684 - Isoxazole analogs as FXR agonists and methods of use thereof
13. 11008304 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
14. 10988458 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
15. 10968249 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof